Refractory Hypocalcemia Following Denosumab Administration in Advanced Breast Cancer: Management Challenges
AACE Endocrinology and Diabetes · 2026-08
DOI: 10.1016/j.aed.2026.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-08. Verfasst von Muhammad Imran Butt und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Butt, M. I., Jacob, I., Zulkifli, N. S., Ciin, L. C., Triay, J., & Sanmugarajah, J. (2026). Refractory Hypocalcemia Following Denosumab Administration in Advanced Breast Cancer: Management Challenges. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.08.002
Vancouver
Butt MI, Jacob I, Zulkifli NS, Ciin LC, Triay J, Sanmugarajah J. Refractory Hypocalcemia Following Denosumab Administration in Advanced Breast Cancer: Management Challenges. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.08.002
BibTeX
@article{Butt2026,
author = {Butt, Muhammad Imran and Jacob, Irene and Zulkifli, Nur Sakinah and Ciin, Louise CH. and Triay, Jessica and Sanmugarajah, Jasotha},
title = {Refractory Hypocalcemia Following Denosumab Administration in Advanced Breast Cancer: Management Challenges},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.08.002}
}
EUVIMED